Status: Recruiting
Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
Aim of this study is to investigate the outcome of NGS MRD based risk stratified treatment for high risk acute lymphoblastic leukemia in children and adolescents.
Participants needed: 116
Trial details
Phase: Phase 2Age: 1-9Biological sex: AllType: InterventionalSponsor: Hee Young JuUpdated: Jun 8, 2025Locations: 9
Eligibility criteria
Newly diagnosed pediatric/adolescent acute lymphomblastic leukemia patient with... [+4]
Steroid administration within 2 weeks before the registration [+6]